YKL-40 as a biomarker in various inflammatory diseases: A review
Biochemia medica · 15.02.2024 · 34 (1) · 42-56
DOI: 10.11613/bm.2024.010502 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochemia medica, online erschienen am 15.12.2023. Verfasst von Nina Blazevic und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Sestre milosrdnice University Hospital Center, Zagreb, Croatia. Hauptthemen laut MEDLINE: Chitinase-3-Like Protein 1, Inflammation, Biomarkers, Disease. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
YKL-40 or Chitinase-3-Like Protein 1 (CHI3L1) is a highly conserved glycoprotein that binds heparin and chitin in a non-enzymatic manner. It is a member of the chitinase protein family 18, subfamily A, and unlike true chitinases, YKL-40 is a chitinase-like protein without enzymatic activity for chitin. Although its accurate function is yet unknown, the pattern of its expression in the normal and disease states suggests its possible engagement in apoptosis, inflammation and remodeling or degradation of the extracellular matrix. During an inflammatory response, YKL-40 is involved in a complicated interaction between host and bacteria, both promoting and attenuating immune response and potentially being served as an autoantigen in a vicious circle of autoimmunity. Based on its pathophysiology and mechanism of action, the aim of this review was to summarize research on the growing role of YKL-40 as a persuasive biomarker for inflammatory diseases’ early diagnosis, prediction and follow-up (e.g., cardiovascular, gastrointestinal, endocrinological, immunological, musculoskeletal, neurological, respiratory, urinary, infectious) with detailed structural and functional background of YKL-40.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, Sestre milosrdnice University Hospital Center, Zagreb, Croatia.
- Department of Laboratory Diagnostics, University Hospital Center Zagreb, Zagreb, Croatia.
- Department of Clinical Chemistry, Sestre milosrdnice University Hospital Center, Zagreb, Croatia.
- Department of Surgery, Sestre milosrdnice University Hospital Center, Zagreb, Croatia.
- Department of Gastroenterology, General Hospital Virovitica, Virovitica, Croatia.
- Department of Internal Medicine, Intensive Care Unit, Sestre milosrdnice University Hospital Center, Zagreb, Croatia.
Zitieren
APA
Blazevic, N., Rogic, D., Pelajic, S., Miler, M., Glavcic, G., Ratkajec, V., Vrkljan, N., Bakula, D., Hrabar, D., & Pavic, T. (2024). YKL-40 as a biomarker in various inflammatory diseases: A review. Biochemia medica, 34(1), 42-56. https://doi.org/10.11613/bm.2024.010502
Vancouver
Blazevic N, Rogic D, Pelajic S, Miler M, Glavcic G, Ratkajec V, et al. YKL-40 as a biomarker in various inflammatory diseases: A review. Biochemia medica. 2024;34(1):42-56. doi:10.11613/bm.2024.010502
BibTeX
@article{Blazevic2024,
author = {Blazevic, Nina and Rogic, Dunja and Pelajic, Stipe and Miler, Marijana and Glavcic, Goran and Ratkajec, Valentina and Vrkljan, Nikolina and Bakula, Dejan and Hrabar, Davor and Pavic, Tajana},
title = {YKL-40 as a biomarker in various inflammatory diseases: A review},
journal = {Biochemia medica},
year = {2024},
volume = {34},
number = {1},
pages = {42--56},
doi = {10.11613/bm.2024.010502}
}
EUVIMED